NASDAQ:COGT
Cogent Biosciences, Inc.
- Stock
Last Close
9.22
26/07 20:00
Market Cap
851.92M
Beta: −0.40
Volume Today
417.71K
Avg: 610.94K
PE Ratio
−2.90
PFCF: −4.64
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 37.50K - | 37.50K 0% | ||||||||
average payables | 1.40M - | 1.43M 2.32% | 2.35M 64.12% | 1.96M 16.74% | 2.11M 7.66% | 4.66M 121.23% | 8.25M 76.91% | |||
average receivables | 879K - | 1.25M 42.09% | 1.83M 46.84% | 1M 45.47% | ||||||
book value per share | 8.95 - | 3.83 57.23% | 9.68 152.89% | 4.17 56.93% | 21.18 408.06% | 4.89 76.91% | 4.35 10.96% | 0.00 99.93% | ||
capex per share | -0.34 - | -0.56 65.85% | -0.12 78.17% | -0.09 28.46% | -0.00 95.09% | -0.04 - | -0.12 197.74% | -0.00 99.97% | ||
capex to depreciation | -11.14 - | -3.98 64.23% | -0.78 80.45% | -0.42 46.64% | -0.03 93.86% | -11.69 - | -1.17 90.02% | -0.78 33.26% | ||
capex to operating cash flow | -0.11 - | 0.18 257.63% | 0.04 80.10% | 0.02 52.13% | 0.00 95.30% | 0.03 - | 0.06 97.75% | 0.02 68.54% | ||
capex to revenue | -0.67 - | -0.52 22.07% | -0.11 79.04% | -0.06 48.30% | -0.00 97.40% | |||||
cash per share | 11.70 - | 5.54 52.67% | 12.63 128.02% | 4.91 61.11% | 21.86 345.02% | 5.01 77.05% | 4.41 11.98% | 0.00 99.92% | ||
days of inventory on hand | ||||||||||
days payables outstanding | ||||||||||
days sales outstanding | 53.30 - | 36.24 32.01% | 62.55 72.60% | 32.45 48.12% | ||||||
debt to assets | 0.02 - | 0.06 254.87% | 0.04 21.71% | 0.12 176.13% | 0.02 83.00% | 0.01 34.49% | 0.07 380.52% | 0.06 7.92% | ||
debt to equity | 0.02 - | 0.10 326.99% | 0.06 35.64% | 0.19 201.19% | 0.02 88.32% | 0.01 33.61% | 0.08 421.60% | 0.07 4.82% | ||
dividend yield | ||||||||||
earnings yield | -0.11 - | -0.30 174.94% | -0.33 11.35% | -0.32 4.87% | -1.38 337.58% | -0.53 61.29% | -0.19 64.22% | -0.20 2.25% | -0.00 99.79% | |
enterprise value | 19.57M - | 48.65M 148.56% | 53.87M 10.72% | -9.45M 117.54% | -112.54M 1,091.39% | 159.33M 241.57% | 558.79M 250.72% | 468.35B 83,715.19% | ||
enterprise value over ebitda | -1.07 - | -1.95 81.49% | -1.55 20.25% | 0.29 118.90% | 1.25 327.42% | -2.11 268.40% | -3.78 78.88% | -2.25K 59,435.65% | ||
ev to operating cash flow | -1.05 - | -1.88 79.33% | -1.66 11.95% | 0.23 113.72% | 3.14 1,279.62% | -2.71 186.37% | -4.71 73.72% | -3.05K 64,627.30% | ||
ev to sales | 3.08 - | 5.82 88.95% | 5.53 4.91% | -0.42 107.59% | -14.30 3,305.54% | |||||
free cash flow per share | 2.69 - | -3.75 239.59% | -3.62 3.52% | -5.31 46.79% | -5.45 2.71% | -3.24 40.66% | -1.38 57.32% | -2.14 54.75% | -0.00 99.91% | |
free cash flow yield | 0.26 - | -0.36 239.59% | -0.35 3.52% | -0.30 13.26% | -1.89 527.70% | -0.29 84.78% | -0.16 44.14% | -0.18 14.86% | -0.00 99.82% | |
graham net net | 7.86 - | 2.81 64.22% | 8.70 209.23% | 2.79 67.93% | 20.39 630.70% | 4.61 77.41% | 3.65 20.83% | 0.00 99.93% | ||
graham number | 24.96 - | 17.23 30.99% | 34.76 101.77% | 19.30 44.47% | 53.45 176.93% | 13.43 74.88% | 14.87 10.76% | 0.01 99.91% | ||
income quality | -2.69 - | 1.03 138.27% | 1.01 1.46% | 0.94 7.17% | 1.30 38.61% | 0.48 63.25% | 0.81 69.66% | 0.85 4.04% | 0.80 5.62% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
interest coverage | -37.06 - | |||||||||
interest debt per share | 0.21 - | 0.37 82.63% | 0.61 62.77% | 0.79 29.72% | 0.47 40.64% | 0.07 84.67% | 0.40 458.74% | 0.00 99.94% | ||
inventory turnover | ||||||||||
invested capital | 0.02 - | 0.10 326.99% | 0.06 35.64% | 0.19 201.19% | 0.02 88.32% | 0.01 33.61% | 0.08 421.60% | 0.07 4.82% | ||
market cap | 60.90M - | 60.90M 0% | 76.92M 26.32% | 109.54M 42.40% | 21.95M 79.97% | 124.44M 467.04% | 375.85M 202.03% | 679.03M 80.66% | 468.39B 68,878.98% | |
net current asset value | 46.57M - | 21.57M 53.68% | 55.31M 156.43% | 22.93M 58.54% | 228.66M 897.22% | 204.72M 10.47% | 219.89M 7.41% | 215.14M 2.16% | ||
net debt to ebitda | 2.27 - | 1.13 50.05% | 1.61 41.84% | 0.98 39.22% | 2.64 170.83% | 2.87 8.68% | 0.81 71.68% | 0.17 79.69% | ||
net income per share | -1.13 - | -3.10 174.94% | -3.45 11.35% | -5.55 60.98% | -3.97 28.40% | -6.00 50.94% | -1.64 72.67% | -2.26 37.76% | -0.00 99.89% | |
operating cash flow per share | 3.03 - | -3.18 205.22% | -3.49 9.72% | -5.22 49.45% | -5.45 4.37% | -3.24 40.62% | -1.34 58.54% | -2.02 50.56% | -0.00 99.90% | |
payables turnover | ||||||||||
receivables turnover | 6.85 - | 10.07 47.08% | 5.84 42.06% | 11.25 92.77% | ||||||
research and ddevelopement to revenue | 2.29 - | 3.46 50.81% | 3.57 3.12% | 3.93 10.22% | 1.94 50.61% | 9.23 375.10% | ||||
return on tangible assets | -0.24 - | -0.52 116.36% | -0.40 22.57% | -0.61 52.42% | -0.26 56.76% | -0.31 16.82% | -0.44 42.53% | -0.61 39.21% | ||
revenue per share | 0.51 - | 1.09 112.83% | 1.13 4.14% | 1.56 38.37% | 2.95 88.79% | 0.71 75.94% | ||||
roe | -0.35 - | -0.90 160.33% | -0.57 36.34% | -0.95 66.25% | -0.28 70.29% | -0.34 18.39% | -0.52 54.71% | -0.75 43.90% | ||
roic | -0.35 - | -0.83 136.35% | -0.59 29.26% | -0.70 19.10% | -0.30 57.33% | -0.34 14.27% | -0.47 39.22% | -0.70 48.61% | ||
sales general and administrative to revenue | 0.91 - | 0.54 40.83% | 0.56 3.63% | 0.77 36.79% | 0.49 36.34% | 2.21 354.05% | ||||
shareholders equity per share | 8.95 - | 3.83 57.23% | 9.68 152.89% | 4.17 56.93% | 21.18 408.06% | 4.89 76.91% | 4.35 10.96% | 0.00 99.93% | ||
stock based compensation to revenue | 0.08 - | 0.16 92.49% | 0.16 0.33% | 0.32 97.77% | 0.14 54.59% | 0.76 430.68% | ||||
tangible asset value | 52.39M - | 28.30M 45.97% | 60.23M 112.80% | 31.76M 47.27% | 234.67M 638.83% | 214.18M 8.73% | 255.74M 19.40% | 257.80M 0.81% | ||
tangible book value per share | 8.95 - | 3.83 57.23% | 9.68 152.89% | 4.17 56.93% | 21.18 408.06% | 4.89 76.91% | 4.35 10.96% | 0.00 99.93% | ||
working capital | 60.99M - | 31.19M 48.87% | 56.06M 79.73% | 27.34M 51.22% | 231.82M 747.81% | 205.56M 11.33% | 238.12M 15.84% | 232.60M 2.32% |
All numbers in USD (except ratios and percentages)